<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title><![CDATA[Pharmaceutical Industry - Newslocker]]></title><link>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/</link><atom:link rel="self" href="https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/rss/" /><atom:link rel="hub" href="http://pubsubhubbub.appspot.com" /><description><![CDATA[Find your latest Pharmaceutical Industry news with just one click. Don't miss out on anything happening in your profession!]]></description><language>en-uk</language><copyright>Copyright (C) 2026 newslocker.com</copyright><lastBuildDate>Sat, 24 Oct 2026 00:37:00 +0200</lastBuildDate><item><title><![CDATA[U.S. Candidate Risk Score Prioritizes Sicker Heart Transplant Candidates]]></title><description><![CDATA[FRIDAY, Oct. 23, 2026-- A U.S.-Candidate Risk Score (US-CRS) prioritizes sicker heart transplant candidates with higher mortality without transplant compared with the current medical urgency status, according to a study published online Oct. 12 in...]]></description><link>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/us-candidate-risk-score-prioritizes-sicker-heart-transplant-candidates/</link><pubDate>Sat, 24 Oct 2026 00:37:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/us-candidate-risk-score-prioritizes-sicker-heart-transplant-candidates/</guid></item><item><title><![CDATA[Patient-Reported Outcomes Worse for Patients With RA Discontinuing TNF Inhibitor]]></title><description><![CDATA[FRIDAY, Oct. 23, 2026-- For patients with rheumatoid arthritis (RA), patient-reported outcomes (PROs) generally worsen shortly after tumor necrosis factor inhibitor (TNFi) discontinuation, according to a study published in the September issue of...]]></description><link>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/patient-reported-outcomes-worse-for-patients-with-ra-discontinuing-tnf-inhibitor/</link><pubDate>Sat, 24 Oct 2026 00:35:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/patient-reported-outcomes-worse-for-patients-with-ra-discontinuing-tnf-inhibitor/</guid></item><item><title><![CDATA[Treating Depression in Pregnancy Influences Infant Brain Development]]></title><description><![CDATA[FRIDAY, Oct. 23, 2026 -- Treating depression with interpersonal psychotherapy during pregnancy influences infant brain development and early emotional function, according to a study published online Oct. 16 in Nature Medicine.<br />
Catherine H. Demers...]]></description><link>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/treating-depression-in-pregnancy-influences-infant-brain-development/</link><pubDate>Fri, 23 Oct 2026 17:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/treating-depression-in-pregnancy-influences-infant-brain-development/</guid></item><item><title><![CDATA[Remission Achievable With Usual Care for Axial Spondyloarthritis]]></title><description><![CDATA[FRIDAY, Oct. 23, 2026 -- For patients with axial spondyloarthritis (axSpA), remission is attainable with usual care, according to a study published in the September issue of the Journal of Rheumatology.<br />
Franziska Kluempers, M.D., from...]]></description><link>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/remission-achievable-with-usual-care-for-axial-spondyloarthritis/</link><pubDate>Fri, 23 Oct 2026 17:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/remission-achievable-with-usual-care-for-axial-spondyloarthritis/</guid></item><item><title><![CDATA[Outcomes Similar for Drug-Coated Balloon, Drug-Eluting Stent in PCI for De Novo Coronary Disease]]></title><description><![CDATA[FRIDAY, Oct. 23, 2026 -- For patients with de novo coronary artery disease undergoing percutaneous coronary intervention (PCI), drug-coated balloon (DCB) and drug-eluting stent (DES) strategies are comparable in terms of cardiovascular death and...]]></description><link>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/outcomes-similar-for-drug-coated-balloon-drug-eluting-stent-in-pci-for-de-novo-coronary-disease/</link><pubDate>Fri, 23 Oct 2026 17:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/outcomes-similar-for-drug-coated-balloon-drug-eluting-stent-in-pci-for-de-novo-coronary-disease/</guid></item><item><title><![CDATA[Once-Daily Oral Icotronkinra Outperforms Placebo in Ulcerative Colitis]]></title><description><![CDATA[FRIDAY, Oct. 23, 2026 -- For patients with moderately to severely active ulcerative colitis, oral icotrokinra, a peptide that blocks the interleukin-23 receptor, yields a clinical response at week 12 significantly more often than placebo, according...]]></description><link>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/once-daily-oral-icotronkinra-outperforms-placebo-in-ulcerative-colitis/</link><pubDate>Fri, 23 Oct 2026 17:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/once-daily-oral-icotronkinra-outperforms-placebo-in-ulcerative-colitis/</guid></item><item><title><![CDATA[DOACs Beneficial for Patients With A-Fib and Prior Intracranial Bleeding]]></title><description><![CDATA[FRIDAY, Oct. 23, 2026 -- For patients with atrial fibrillation (AF) and prior intracranial bleeding, direct oral anticoagulants (DOACs) are associated with a reduced risk for ischemic stroke (IS) and death, without an increased risk for intracranial...]]></description><link>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/doacs-beneficial-for-patients-with-a-fib-and-prior-intracranial-bleeding/</link><pubDate>Fri, 23 Oct 2026 17:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/doacs-beneficial-for-patients-with-a-fib-and-prior-intracranial-bleeding/</guid></item><item><title><![CDATA[UEG: Disability Burden for Alcohol-Related Cirrhosis, Heart Failure Identified]]></title><description><![CDATA[THURSDAY, Oct. 22, 2026-- Western Europe has the highest disability burden associated with alcohol-related cirrhosis complicated by heart failure, according to a study presented at UEG Week, the annual meeting of United European Gastroenterology...]]></description><link>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/ueg-disability-burden-for-alcohol-related-cirrhosis-heart-failure-identified/</link><pubDate>Thu, 22 Oct 2026 22:26:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/ueg-disability-burden-for-alcohol-related-cirrhosis-heart-failure-identified/</guid></item><item><title><![CDATA[Prevalence of Binge Eating 40.5 Percent in U.S. High School Students]]></title><description><![CDATA[THURSDAY, Oct. 22, 2026-- The prevalence of binge eating at least one day in the past 30 days is 40.5 percent in U.S. high school students, according to a study published online Oct. 15 in Morbidity and Mortality Weekly Report.Ryan Saelee, Ph.D...]]></description><link>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/prevalence-of-binge-eating-405-percent-in-us-high-school-students/</link><pubDate>Thu, 22 Oct 2026 22:23:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/prevalence-of-binge-eating-405-percent-in-us-high-school-students/</guid></item><item><title><![CDATA[Early Uptake Was Rapid for Oral Semaglutide Relative to Injectables]]></title><description><![CDATA[THURSDAY, Oct. 22, 2026-- Early uptake was rapid for oral semaglutide (Wegovy pill) relative to injectable incretin-based weight management therapies, according to a study published online Oct. 13 in Annals of Internal Medicine.Yara Jelwan, M.D...]]></description><link>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/early-uptake-was-rapid-for-oral-semaglutide-relative-to-injectables/</link><pubDate>Thu, 22 Oct 2026 17:42:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/early-uptake-was-rapid-for-oral-semaglutide-relative-to-injectables/</guid></item><item><title><![CDATA[Initiating Vasopressin at Lower Threshold Does Not Reduce Septic Shock Mortality]]></title><description><![CDATA[THURSDAY, Oct. 22, 2026-- A strategy recommending initiation of vasopressin at a lower dose of other vasopressors does not reduce 28-day mortality for patients in septic shock, according to a study published online Oct. 14 in the Journal of the...]]></description><link>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/initiating-vasopressin-at-lower-threshold-does-not-reduce-septic-shock-mortality/</link><pubDate>Thu, 22 Oct 2026 17:39:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/initiating-vasopressin-at-lower-threshold-does-not-reduce-septic-shock-mortality/</guid></item><item><title><![CDATA[Cardiovascular Consequences of Continued Anabolic-Androgenic Steroid Use Identified]]></title><description><![CDATA[THURSDAY, Oct. 22 2026-- Continued anabolic-androgenic steroid (AAS) use is associated with sustained left ventricular (LV) hypertrophy, LV systolic dysfunction, and worsening diastolic function, which is reversible after discontinuation of AAS...]]></description><link>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/cardiovascular-consequences-of-continued-anabolic-androgenic-steroid-use-identified/</link><pubDate>Thu, 22 Oct 2026 17:34:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/cardiovascular-consequences-of-continued-anabolic-androgenic-steroid-use-identified/</guid></item><item><title><![CDATA[Medical Device Adverse Event Reports Often Incomplete, Inaccurate]]></title><description><![CDATA[THURSDAY, Oct. 22, 2026-- Medical device adverse event reports are frequently incomplete, inaccurate, and delayed, according to a study published online Oct. 14 in The BMJ.Alyssa Zhou, from the University of California, San Francisco, and...]]></description><link>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/medical-device-adverse-event-reports-often-incomplete-inaccurate/</link><pubDate>Thu, 22 Oct 2026 17:25:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/medical-device-adverse-event-reports-often-incomplete-inaccurate/</guid></item><item><title><![CDATA[Early Rhythm Control Beneficial for Patients With A-Fib, Stroke]]></title><description><![CDATA[THURSDAY, Oct. 22, 2026 -- For patients with atrial fibrillation (AF) and acute ischemic stroke, early initiation of rhythm control is associated with a lower risk for recurrent stroke or systemic embolism (SE), according to a study published online...]]></description><link>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/early-rhythm-control-beneficial-for-patients-with-a-fib-stroke/</link><pubDate>Thu, 22 Oct 2026 17:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/early-rhythm-control-beneficial-for-patients-with-a-fib-stroke/</guid></item><item><title><![CDATA[AHA: Risk for Falls Elevated in Older Adults With Masked Hypertension]]></title><description><![CDATA[THURSDAY, Oct. 22, 2026 -- Masked hypertension (higher home than office blood pressure [BP]) is associated with a higher risk for falls in older adults, according to a study presented at the American Heart Association Hypertension Scientific...]]></description><link>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/aha-risk-for-falls-elevated-in-older-adults-with-masked-hypertension/</link><pubDate>Thu, 22 Oct 2026 17:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/aha-risk-for-falls-elevated-in-older-adults-with-masked-hypertension/</guid></item><item><title><![CDATA[Adults With Type 1 Diabetes More Likely to Have Depressive, Anxiety Symptoms]]></title><description><![CDATA[THURSDAY, Oct. 22, 2026 -- Adults with type 1 diabetes have a higher prevalence of depressive and generalized anxiety disorder (GAD) symptoms than those with type 2 diabetes or without diabetes, according to a research letter published online Oct...]]></description><link>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/adults-with-type-1-diabetes-more-likely-to-have-depressive-anxiety-symptoms/</link><pubDate>Thu, 22 Oct 2026 17:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/adults-with-type-1-diabetes-more-likely-to-have-depressive-anxiety-symptoms/</guid></item><item><title><![CDATA[AACR: Rural Populations Have Higher Breast Cancer Mortality]]></title><description><![CDATA[THURSDAY, Oct. 22, 2026 -- Rural populations experience higher breast cancer mortality, and the rural-urban gap is expected to widen by 2035, according to a study presented at the American Association for Cancer Research Conference on The Science of...]]></description><link>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/aacr-rural-populations-have-higher-breast-cancer-mortality/</link><pubDate>Thu, 22 Oct 2026 17:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/aacr-rural-populations-have-higher-breast-cancer-mortality/</guid></item><item><title><![CDATA[HbA1c, Weight Increases Seen After Antipsychotic Initiation]]></title><description><![CDATA[WEDNESDAY, Oct. 21, 2026-- Antipsychotic treatment initiation is associated with rapid increases in hemoglobin A1c (HbA1c) and weight, according to a study published in the November issue of The Lancet Psychiatry.Juan Carlos Bazo-Alvarez, Ph.D...]]></description><link>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/hba1c-weight-increases-seen-after-antipsychotic-initiation/</link><pubDate>Thu, 22 Oct 2026 00:21:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/hba1c-weight-increases-seen-after-antipsychotic-initiation/</guid></item><item><title><![CDATA[Some Benefits Found for GLP-1 Receptor Agonists in Older Adults With MASLD]]></title><description><![CDATA[WEDNESDAY, Oct. 21, 2026-- For older adults with metabolic dysfunction-associated steatotic liver disease (MASLD), glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment is associated with lower risks for hepatic decompensation...]]></description><link>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/some-benefits-found-for-glp-1-receptor-agonists-in-older-adults-with-masld/</link><pubDate>Thu, 22 Oct 2026 00:15:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/some-benefits-found-for-glp-1-receptor-agonists-in-older-adults-with-masld/</guid></item><item><title><![CDATA[Recommendations Updated for Management of Tinnitus]]></title><description><![CDATA[WEDNESDAY, Oct. 21, 2026 -- Updated recommendations are presented for the management of tinnitus in a clinical practice guideline issued by the American Academy of Otolaryngology-Head and Neck Surgery Foundation and published online Oct. 12 in...]]></description><link>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/recommendations-updated-for-management-of-tinnitus/</link><pubDate>Wed, 21 Oct 2026 17:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/recommendations-updated-for-management-of-tinnitus/</guid></item></channel></rss>